ASCRS

The investigators conducted a multicenter, prospective, open-label, phase 4 study in which they evaluated the patients’ and investigators’ impressions of the drug.

Authors looked at 6 unexpected cases of endophthalmitis after cataract extraction during 1 day of cataract surgeries.

George O. Waring IV, MD, FACS, provides an overview of his presentation at ASCRS 2024, highlighting outcomes for the safety and effectiveness of LASIK performed using an updated laser ablation algorithm for the correction of myopia and myopic astigmatism.

A recent study showed that adjunctive fragmentation pre-treatment of the crystalline lens using the miLoop showed improved lensectomy time and fluidic efficiency

Neda Nikpoor, MD, sat down to discuss her presentation on the single-site study on the effectiveness of a sterile model with two ALLYs, in two operating rooms against a model with only one laser for two rooms at this year's ASCRS meeting held in Boston, Massachusetts.

Sean Hanlon, CEO of CoFi, a payment software company, talks about the company's recent integration with CareCredit.

Rich Small, CEO of Neurotech Pharmaceuticals, provides an update on the months ahead for NT-501 encapsulated cell therapy

Ula Jurkunas, MD, sat down to discuss her presentation on the management of anterior corneal disease at this year's ASCRS meeting held in Boston, Massachusetts.

Roger Kennedy, director of marketing at BioTissue sat down to discuss the new products the company will be unveiling at this year's ASCRS meeting held in Boston, Massachusetts.

Jennifer Loh, MD, sat down to discuss her presentation on major eye issues that can interfere with refractive cataract surgery, specifically dry eye disease, at this year's ASCRS meeting held in Boston, Massachusetts.

Spencer will formally receive his award during the 2024 ASCRS Annual meeting, being held April 5 to 8, as part of its 50th anniversary celebration.

The company said the module, which includes real-world data on more than 10 million patients, will help advance research and accelerate therapy development for dry eye disease and other ocular surface disorders.

Thompson will assume the presidency of the ASCRS, which is celebrating its 50th anniversary in 2024. The organization kicks off its 2024 annual meeting Friday at Boston Convention and Exhibition Center in Boston.

The company’s Lacrifill canalicular gel is a cross-linked hyaluronic acid derivative and is FDA-cleared to temporarily block tear drainage by the occlusion of the canalicular system.

The company announced it will share clinical data at Eyecelerator and the American Society of Cataract and Refractive Surgery 2024 Annual Meeting in Boston.

Conference defines the future of anterior segment surgery.

The benefit concert will be held at 8 pm April 7 at The Sinclair in Cambridge, and will feature performances by ophthalmologists and industry partners.

According to the company, its Virtual Eye Pro features improve visual field testing for practice and patients.

In a presentation at the American Society of Cataract and Refractive Surgery meeting in San Diego, Kenneth A. Beckman, MD, FACS, discussed the current status of corneal crosslinking with some emerging treatments, including epi-on crosslinking.

Steven Greenstein, MD, sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss his presentation about the 10-year follow-up for collagen cross-linking and keratoconus ectasia.

Jeff Wongs, MD, discussed his study to assess the benefits of cryopreserved amniotic membrane prior to cataract surgery to restore the ocular surface and improve the accuracy of pre-op biometric readings

Jason Bacharach, MD, and Chris Pearson discussed the Preservative Freedom coalition from Théa Pharmaceutical at the 2023 ASCRS annual meeting in San Diego.

Lori Pacheco, RN, CRNO, discussed sports-related eye injuries and how to prevent them at the 2023 ASCRS annual meeting in San Diego.

Patrick Spencer, DO, discussed the safety and effectiveness comparison of hydrogel-based intracanalicular dexamethasone insert placement in the lower versus the upper punctum at the 2023 ASCRS annual meeting in San Diego.

John Hovanesian, MD, discussed his paper on the Apthera small aperture implant for patients with low degrees of astigmatism at the 2023 ASCRS annual meeting in San Diego.

Mahmoud Khaimi, MD, briefly discussed the launch of the iTrack Advance handheld device at the 2023 ASCRS annual meeting in San Diego.

Lisa Nijm, MD, discussed Preservative Freedom, a coalition that has been put together by Thea to help bring attention and bring awareness to creating preservative-free drops for all patients at the 2023 ASCRS annual meeting in San Diego.

Mitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.

Sam Garg, MD, discussed his paper on the 36-month outcomes for the Juvene modular intraocular lens at the 2023 ASCRS annual meeting in San Diego.